NCT05686837 Prospective Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria Status ENROLLING_BY_INVITATION Phase N/A
NCT05668741 A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05641298 Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations Status WITHDRAWN Phase PHASE2
NCT05639556 Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05635266 Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives Status RECRUITING Phase N/A
NCT05599958 Clinical and Genetic Profile of Pediatric Patients With Cystic Fibrosis in Sohag. Status COMPLETED Phase N/A
NCT05599230 Daily Monitoring of Respiratory Symptoms and Spirometry During ETI Treatment in Persons With Cystic Fibrosis. Status UNKNOWN Phase N/A
NCT05590169 Effects of Telerehabilitation-based Exercises in Cystic Fibrosis Status COMPLETED Phase NA
NCT05584982 Clinical Performance of the AtbFinder® Test System for Selection of Antibiotic Therapy in Persons With Cystic Fibrosis Status COMPLETED Phase NA
NCT05581056 Evaluation of the Evolution of Quality of Life in Relation to Naso-sinus Symptomatology Under Treatment With CFTE Modulators in Children Aged 6 to 11 Years With Cystic Fibrosis With Compatible Mutation Status COMPLETED Phase N/A
NCT05576324 Effect of the CFTR-modulating Triple Therapy Elexacaftor - Tezacaftor - Ivacaftor Status UNKNOWN Phase N/A
NCT05561764 Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis Status TERMINATED Phase PHASE4
NCT05548283 Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study Status RECRUITING Phase PHASE4
NCT05535959 A Study to Evaluate the Relative Bioavailability of a Fixed-dose Combination Tablet of VX-121/Tezacaftor/Deutivacaftor Status COMPLETED Phase PHASE1